Novartis

Novartis mission

8 years ago - 1:16

Novartis

Novartis Life

6 years ago - 2:10

Novartis

‘Your Attention, Please’

1 month ago - 1:01

CNBC International Live

Novartis not joining the 'frenzy' of weight loss drugs, CEO says

5 months ago - 3:45

CNBC Television

Novartis CEO: Our leukemia drug Scemblix is a potential $3 billion plus medicine

9 months ago - 4:43

Novartis

Novartis – Who We Are

2 years ago - 0:52

Yahoo Finance

AI, vaccine distrust, & the future of healthcare: Novartis CEO

2 months ago - 24:01

Novartis

Novartis Campus Lecture - RNA Revolution: A Conversation with Nobel Prize winner Katalin Karikó

8 months ago - 1:13:57

Bloomberg Television

Novartis Cancer Drug Is Approved With $475,000 Price Tag

7 years ago - 1:13

Novartis

Novartis is an innovative medicines company. Every day, we working to reimagine medicine to improve and extend people's lives ...

@Novartis subscribers

WJHL

Novartis, Sandoz recall 12 medications over packaging concerns

6 years ago - 0:34

Yahoo Finance

Novartis CEO discusses how AI will impact drug development

1 year ago - 6:51

Novartis

Novartis Research & Development

5 years ago - 3:01

Novartis

25 Years of Novartis – Continuing our innovation journey

4 years ago - 2:59

Novartis

Reimagining Medicine with Data & Digital | Novartis CEO at #VivaTech19

5 years ago - 23:37

Novartis

How does Novartis create value for stakeholders and society?

2 years ago - 2:16

Novartis

Corporate responsibility at Novartis

7 years ago - 1:37

Novartis

Novartis Oncology - BOLD Science. Transforming Lives. Striving For Cures.

3 years ago - 0:59

Novartis

The Novartis Commitment to Patients and Caregivers

6 years ago - 2:48

David Rubenstein

Novartis CEO Vas Narasimhan on The David Rubenstein Show

1 year ago - 24:07

CNBC International Live

Novartis CEO says FDA's extended approval of breast cancer drug is a 'landmark' for the firm

5 months ago - 1:15

Novartis

Manufacturing CAR-T Cell Therapies: The Novartis Approach

7 years ago - 2:14

Berkeley Haas

Joe Jimenez, CEO of Novartis at Berkeley-Haas

11 years ago - 57:40

Novartis

Next Generation Scientist 2024

5 months ago - 4:34

Novartis

We belong here

9 months ago - 1:24

Novartis

Novartis ESG Investor Day 2021: 6 key takeaways

3 years ago - 1:09

CNBC Television

Novartis CEO on new cancer therapy programs

3 years ago - 4:22

Novartis

The Novartis Biome - a catalyst for impactful digital collaborations

4 years ago - 1:10

Novartis

Machine learning is changing the way we do science at Novartis

6 years ago - 0:39

Novartis

Research and Development: It’s our heartbeat.

3 years ago - 1:12

Novartis

Novartis transformation into a pure-play Innovative Medicines company

2 years ago - 4:17

Novartis

Novartis Delivery

7 years ago - 1:40

Novartis

The future of Novartis

5 years ago - 1:52

Bloomberg Television

Novartis Can Meet Growing Demand for Gene Therapy: CEO

5 years ago - 4:42

Novartis

Novartis Targets Cancer Genomics for Precision Medicine

9 years ago - 2:02

Novartis

Ending the pandemic – How Novartis supports the global vaccine supply

3 years ago - 0:44

Novartis

Novartis Full Year Results 2019

5 years ago - 3:52

The Wall Street Journal

Novartis and Glaxo Deal Reshapes Pharma Industry

10 years ago - 3:54

Yahoo Finance

Novartis ‘focusing on high-end, innovative medicines,’ CEO says

1 year ago - 11:50

Medical Dialogues

Novartis Ruxolitinib Gets CDSCO Panel Nod For Acute And Chronic Graft Versus Host Disease

2 years ago - 1:52